GBS: Pathophysiology Causes Symptoms and Management

 Guillain-Barré Syndrome (GBS)

Guillain-Barré Syndrome is a rapidly progressing condition characterized by motor paralysis with reduced or absent reflexes, sometimes accompanied by sensory symptoms. It typically begins as an ascending weakness, often first noticed as unstable or “rubbery” legs. The weakness develops over hours to days and is commonly associated with tingling sensations in the limbs. The legs are usually more affected than the arms, and about half of patients experience weakness in both sides of the face. Involvement of lower cranial nerves can lead to difficulty swallowing and managing secretions, which may initially resemble brainstem stroke. Early symptoms often include pain in the neck, shoulders, back, or along the spine.

1. Pathophysiology

Autoimmune Misidentification

GBS arises from an autoimmune response gone wrong. Most cases occur after recovery from a mild infection, such as a respiratory or gastrointestinal illness.

• Trigger: The immune system responds to an infection (e.g., Campylobacter jejuni).
• Cross-Reactivity: Antibodies produced against the pathogen mistakenly recognize components of peripheral nerves due to structural similarities (molecular mimicry).
• Immune Attack: These antibodies and immune cells then damage the body’s own nerves.

Nerve Damage Mechanisms

Peripheral nerves function like insulated electrical wires, and GBS can damage them in two main ways:

• AIDP (common in Western countries): The immune response targets the myelin sheath, the insulating layer around nerves. This slows or blocks nerve signal transmission (demyelination).
• AMAN/AMSAN (more common in Asia): The immune attack targets the axon itself, which can cause more severe damage and prolonged recovery.

Types of GBS

Different forms of GBS are classified based on the site of immune attack and confirmed through electrodiagnostic testing:

• AIDP: Affects myelin; shows slowed conduction and conduction block; most common in the West.
• AMAN: Targets motor axons; shows reduced motor responses with preserved sensory function.
• AMSAN: Affects both motor and sensory axons; generally more severe.
• Miller Fisher Syndrome: A rare variant affecting cranial nerves, often associated with anti-GQ1b antibodies and more common in Asia.

2. Signs and Symptoms

GBS is identified by the rapid progression of symptoms, usually peaking within 2–4 weeks.

Typical Onset and Progression

• Initial Symptoms: Tingling and numbness begin in the feet and legs.
• Ascending Weakness: Weakness spreads upward to the arms and face, making movements like walking or standing difficult.
• Areflexia: Loss of deep tendon reflexes is a key diagnostic feature.

Serious Complications

GBS can affect multiple body systems:

• Bulbar Weakness: Leads to difficulty speaking and swallowing.
• Autonomic Dysfunction: Causes instability in heart rate, blood pressure, and digestion, potentially leading to dangerous complications.
• Respiratory Failure: If breathing muscles are affected, mechanical ventilation may be required; this occurs in roughly one-third of cases.

3. Causes and Triggers

GBS is not contagious or inherited but typically follows an immune response to infection.

Common Triggers

• Campylobacter jejuni (most common cause)
• Viral infections such as CMV, EBV, Zika virus, and COVID-19
• Vaccines (rarely associated; risk is significantly lower than infection-related risk)

Risk Factors

• Can occur at any age but is more common in older adults
• Slightly higher incidence in males
• Rare overall, affecting about 1–2 individuals per 100,000 annually

4. Management and Recovery

Because GBS progresses quickly, early treatment is critical.

Initial Treatment

Therapy should begin within two weeks of symptom onset:

• IVIg (Intravenous Immunoglobulin): Provides normal antibodies to neutralize harmful ones.
• Plasma Exchange (PLEX): Removes antibody-containing plasma and replaces it with clean fluid.

Both treatments are equally effective in reducing recovery time and lowering the need for ventilatory support.

Supportive Care

• Close monitoring of respiratory function
• Management of blood pressure fluctuations, cardiac issues, and Nerve pain
• Intensive care when necessary

Rehabilitation

Recovery can take weeks to months:

• Physical and Occupational Therapy: Help maintain mobility, prevent complications, and rebuild strength
• Neurorehabilitation: A multidisciplinary approach to address long-term weakness, fatigue, and psychological effects

Although GBS can be severe, most patients achieve full or near-full recovery with timely treatment and rehabilitation.

Early diagnosis and prompt treatment are essential, as starting IVIg or plasma exchange within the first two weeks significantly improves recovery outcomes and reduces long-term disability.

FAQ GBS

Disclaimer: The information provided in this blog post is for educational and informational purposes only and should not be considered medical advice. It is not intended to replace professional medical consultation, diagnosis, or treatment. Always seek the guidance of a qualified healthcare professional regarding any medical condition or health-related concerns. The author and publisher are not responsible for any actions taken based on the information presented in this article.